----
Current ValuationThe current P/E ratio is 4.00, within the reasonable range, cheaper than 41.38% of the time in the past 1 years, and the industry ranks 3/44, the industry Median -0.41.
4xP/E
$6.18Stock price
$1.54Earnings per share
4xP/E
Stock price$6.18Earnings per share$1.54
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 3.82x
- Typical range
- 1.82x–7.34x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
017345168
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
EMBCUSEmbecta | 4.00x | 26.95% | $350.16M |
ADVBUSAdvanced Biomed | 1.27x | -- | $8.49M |
MHUAFUSMEIHUA INTL MEDICAL TECH CO LTD | 0.82x | -- | $5.56M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
